William Towner
Internal Medicine · Los Angeles, CANPI 1538230412
Payments from drug & device makers
Across 1,027 payments — averaging $26,633 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$12.1M
- Pfizer$6M
- Modernatx, Inc.$2.9M
- Janssen Research & Development, LLC$2.4M
- Viiv Healthcare Company$1.9M
- Merck$721K
- plus $1.3M from 5 others
Across 11 payments — averaging $1051.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$10K
- GSK$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 66 | $12,123,370 |
| Pfizer | 297 | $5,963,650 |
| Modernatx, Inc. | 99 | $2,947,864 |
| Janssen Research & Development, LLC | 121 | $2,420,839 |
| Viiv Healthcare Company | 287 | $1,851,187 |
| Merck | 62 | $721,214 |
| Astrazeneca UK Limited | 5 | $700,438 |
| GSK | 77 | $516,106 |
| Sanofi Pasteur Inc. | 10 | $76,996 |
| AstraZeneca | 2 | $30,288 |
| Abbott | 1 | $150 |
How this compares
$27,352,103 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Los Angeles
- Herbert EradatLos Angeles$11.6M
- Deborah WongLos Angeles$10.7M
- Robin KelleyLos Angeles$5.8M
- David GuzmanLos Angeles$4.3M
- Siwen Hu-LieskovanLos Angeles$2.9M
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.